Blue Crest Capital Management LTD Boston Scientific Corp Transaction History

Blue Crest Capital Management LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $207,414 - $230,138	4,600 New	4,600 $230,000
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $2.4 Million - $3.2 Million	67,975 New	67,975 $2.53 Million
Q3 2021 Nov 15, 2021	SELL	$41.23 - $45.88 $2.94 Million - $3.27 Million	-71,254 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$38.58 - $44.24 $2.75 Million - $3.15 Million	71,254 New	71,254 $3.05 Million
Q1 2021 May 17, 2021	SELL	$35.27 - $39.67 $6.47 Million - $7.27 Million	-183,363 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$33.15 - $41.97 $2.51 Million - $3.17 Million	75,614 Added 70.18%	183,363 $6.59 Million
Q3 2020 Nov 16, 2020	BUY	$34.44 - $42.23 $3.71 Million - $4.55 Million	107,749 New	107,749 $4.12 Million
Q4 2019 Feb 14, 2020	SELL	$37.87 - $45.37 $243,352 - $291,547	-6,426 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$40.31 - $43.45 $259,032 - $279,209	6,426 New	6,426 $261,000
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $1.11 Million - $1.37 Million	-31,762 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$32.91 - $40.75 $529,587 - $655,749	16,092 Added 102.69%	31,762 $1.22 Million
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $41,788 - $51,415	1,317 Added 9.18%	15,670 $554,000
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $471,208 - $554,456	14,353 New	14,353 $553,000
Q1 2018 May 15, 2018	SELL	$25.2 - $28.54 $535,726 - $606,731	-21,259 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $527,010 - $633,518	21,259	21,259 $527,000

1,607

1.19B

6.83M

10.1M

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $152B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.